Sendai viral vector mediated angiopoietin-1 gene transfer for experimental ischemic limb disease

被引:27
作者
Huang, Jianhua [1 ,2 ]
Inoue, Makoto [3 ]
Hasegawa, Mamoru [3 ]
Tomihara, Kei [1 ]
Tanaka, Toshihiro [1 ]
Chen, Jiahua [2 ]
Hamada, Hirofumi [1 ]
机构
[1] Sapporo Med Univ, Dept Mol Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan
[2] NingXia Peoples Hosp, Dept Thorac & Cardiovasc Surg, Yinchuan 750021, Peoples R China
[3] DNAVEC Res Corp, Tsukuba, Ibaraki, Japan
关键词
Peripheral arterial obstructive disease; Sendai virus vector; Angiopoietin-1; Ischemia; Lower limb; Rat; ENDOTHELIAL GROWTH-FACTOR; VIRUS VECTORS; AUGMENTS REVASCULARIZATION; INTRAMUSCULAR INJECTION; CELL-SURVIVAL; TIE2; RECEPTOR; EXPRESSION; RNA; ANGIOGENESIS; VEGF;
D O I
10.1007/s10456-009-9144-6
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Sendai virus vector is emerging as a promising vector for gene therapy, and angiopoietin-1 (Ang-1) has been reported to improve the blood flow recovery in the ischemic limb or heart. In this study, we constructed a human Ang-1-expressing Sendai viral vector (SeVhAng-1) and injected it into the ischemic limb of rats. We found that SeVhAng-1 improved the blood flow recovery and increased the capillary density of the ischemic limb, compared with the controls. We also found that SeVhAng-1 increased p-Akt during the early period of limb ischemia, and decreased apoptosis in ischemic limb. It suggests that SeVhAng-1 may serve as a potential therapeutic tool in ischemic limb disease.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 33 条
[1]   Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor [J].
Baumgartner, I ;
Rauh, G ;
Pieczek, A ;
Wuensch, D ;
Magner, M ;
Kearney, M ;
Schainfeld, R ;
Isner, JM .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (11) :880-884
[2]   Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [J].
Baumgartner, I ;
Pieczek, A ;
Manor, O ;
Blair, R ;
Kearney, M ;
Walsh, K ;
Isner, JM .
CIRCULATION, 1998, 97 (12) :1114-1123
[3]   Sendai virus vectors as an emerging negative-strand RNA viral vector system [J].
Bitzer, M ;
Armeanu, S ;
Lauer, UM ;
Neubert, WJ .
JOURNAL OF GENE MEDICINE, 2003, 5 (07) :543-553
[4]   Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins [J].
Dallabrida, SM ;
Ismail, N ;
Oberle, JR ;
Himes, BE ;
Rupnick, MA .
CIRCULATION RESEARCH, 2005, 96 (04)
[5]   Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169
[6]   EUKARYOTIC TRANSIENT-EXPRESSION SYSTEM BASED ON RECOMBINANT VACCINIA VIRUS THAT SYNTHESIZES BACTERIOPHAGE-T7 RNA-POLYMERASE [J].
FUERST, TR ;
NILES, EG ;
STUDIER, FW ;
MOSS, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) :8122-8126
[7]   Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development [J].
Gale, NW ;
Yancopoulos, GD .
GENES & DEVELOPMENT, 1999, 13 (09) :1055-1066
[8]   Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus [J].
Hasan, MK ;
Kato, A ;
Shioda, T ;
Sakai, Y ;
Yu, DS ;
Nagai, Y .
JOURNAL OF GENERAL VIROLOGY, 1997, 78 :2813-2820
[9]   Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF [J].
Holash, J ;
Maisonpierre, PC ;
Compton, D ;
Boland, P ;
Alexander, CR ;
Zagzag, D ;
Yancopoulos, GD ;
Wiegand, SJ .
SCIENCE, 1999, 284 (5422) :1994-1998
[10]   Bcl-xL gene transfer protects the heart against ischemia/reperfusion injury [J].
Huang, JH ;
Ito, Y ;
Morikawa, M ;
Uchida, H ;
Kobune, M ;
Sasaki, K ;
Abe, T ;
Hamada, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 311 (01) :64-70